The aim of this thesis was to explore whether photobiomodulation improved behaviour and offered neuroprotection in animal models of Parkinson's disease and in ageing. The results are presented as publications following a literature review and ending with a general discussion. For Parkinson's disease, a mouse and monkey MPTP model were used, while for ageing, the twelve month mouse model was used. Photobiomodulation was applied either extracranially in mice or intracranially in monkeys. These applications were used as to ensure that photobiomodulation reached the distressed cells directly, offering the best chance of survival. There were five major sets of results. First, photobiomodulation led to improvements in locomotive behaviour in th...
The motor deficits seen in Parkinson’s disease (PD) are the result of a loss of catecholaminergic ne...
Current treatments for Parkinson’s disease (PD) are primarily symptomatic, leaving a need for treatm...
Despite the different animal models of Parkinson's disease developed during the last years, they sti...
Background: Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few...
BACKGROUND Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure and few ...
<div><p>Converging lines of evidence indicate that near-infrared light treatment, also known as phot...
Converging lines of evidence indicate that near-infrared light treatment, also known as photobiomodu...
Current treatments for Parkinson’s disease (PD) are merely symptomatic and do not slow neuronal loss...
Abstract Background Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure...
Introduction: Parkinson's disease is a progressive and severe neurodegenerative disorder of the cent...
Objective: To assess whether remote application of photobiomodulation (PBM) is effective in reducing...
Transcranial photobiomodulation (PBM), which involves the application of low-intensity red to near-i...
Parkinson’s disease (PD) is a chronic neurodegenerative condition that emerges from dysfunction in m...
Converging lines of evidence indicate that near-infrared light treatment, also known as photobiomodu...
The global aim of this thesis was to explore the effect of photobiomodulation (PBM) on the human bra...
The motor deficits seen in Parkinson’s disease (PD) are the result of a loss of catecholaminergic ne...
Current treatments for Parkinson’s disease (PD) are primarily symptomatic, leaving a need for treatm...
Despite the different animal models of Parkinson's disease developed during the last years, they sti...
Background: Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few...
BACKGROUND Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure and few ...
<div><p>Converging lines of evidence indicate that near-infrared light treatment, also known as phot...
Converging lines of evidence indicate that near-infrared light treatment, also known as photobiomodu...
Current treatments for Parkinson’s disease (PD) are merely symptomatic and do not slow neuronal loss...
Abstract Background Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure...
Introduction: Parkinson's disease is a progressive and severe neurodegenerative disorder of the cent...
Objective: To assess whether remote application of photobiomodulation (PBM) is effective in reducing...
Transcranial photobiomodulation (PBM), which involves the application of low-intensity red to near-i...
Parkinson’s disease (PD) is a chronic neurodegenerative condition that emerges from dysfunction in m...
Converging lines of evidence indicate that near-infrared light treatment, also known as photobiomodu...
The global aim of this thesis was to explore the effect of photobiomodulation (PBM) on the human bra...
The motor deficits seen in Parkinson’s disease (PD) are the result of a loss of catecholaminergic ne...
Current treatments for Parkinson’s disease (PD) are primarily symptomatic, leaving a need for treatm...
Despite the different animal models of Parkinson's disease developed during the last years, they sti...